Retraction

Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate

Retraction Details

Citations (21)

21
Total Citations
4
Post-Retraction
(19.0%)
16
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
3 After 2+ years
1299 Days since retraction (latest)
Association between methylphenidate use and long-term cardiovascular risk in paediatric patients with attention deficit and hyperactivity disorder
Heng-Ching Liao, Chien‐Ning Hsu, Fang‐Ju Lin et al. (5 authors)
BMJ Paediatrics Open Open Access
Published: Sep 2024
1299 days after retraction
Methylphenidate-associated chest pain in a child
Ruziana Masiran, Mohamad Nizam Adha Ilias, Putri Yubbu
Drug and Therapeutics Bulletin
Published: Jun 2024
1216 days after retraction
Methylphenidate-associated chest pain in a child
Ruziana Masiran, Mohamad Nizam Adha Ilias, Putri Yubbu
BMJ Case Reports
Published: Nov 2023
994 days after retraction
Association between methylphenidate and risk of myocardial infarction: A multinational self‐controlled case series study
Han Eol Jeong, Hyesung Lee, Edward Chia‐Cheng Lai et al. (10 authors)
Pharmacoepidemiology and Drug Safety Open Access
Published: Jul 2021
4 citations
143 days after retraction
Retracted: Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
Case Reports in Pediatrics
Case Reports in Pediatrics Open Access
Published: Feb 2021
Same day as retraction
Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate
Thomas Stammschulte, Martina Pitzer, Wolfgang Rascher et al. (7 authors)
European Child & Adolescent Psychiatry
Published: Feb 2021
7 citations
7 days before retraction
Short Term Methylphenidate Treatment Does Not Increase Myocardial Injury in the Ischemic Rat Heart
Sarah L. Seeley, Manoranjan S. D’Souza, Thorne S. Stoops et al. (4 authors)
Physiological Research Open Access
Published: Oct 2020
2 citations
102 days before retraction
Dikkat Eksikliği ve Hiperaktivite Bozukluğunda Kullanılan İlaç Tedavisinin Kardiyolojik Açıdan Güvenilirliğinin İncelenmesi
Ayşe Nihal Eraslan, Rezzan AYDIN GÖRÜCÜ, Fatih Atík et al. (4 authors)
Çocuk ve Gelişim Dergisi Open Access
Published: Jun 2020
230 days before retraction
Effects of medications on ventricular repolarization in children with attention deficit hyperactivity disorder
Yelda Türkmenoğlu, Chinare Esedova, Melis Akpınar et al. (5 authors)
International Clinical Psychopharmacology
Published: Oct 2019
7 citations
481 days before retraction
A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys
James D. Wilkinson, Ralph Callicott, William F. Salminen et al. (16 authors)
Pediatric Research Open Access
Published: Dec 2018
7 citations
786 days before retraction
Paper citing Cardiac Arrest following a Myocardial Infarction i...
Unknown Authors
Unknown Journal
Published: Dec 2018
802 days before retraction
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies
Ole Jakob Storebø, N. Strandberg Pedersen, E Ramstad et al. (22 authors)
Cochrane library Open Access
Published: May 2018
295 citations
1007 days before retraction
Methylphenidate clinically oral doses improved brain and heart glutathione redox status and evoked renal and cardiac tissue injury in rats
Sara Loureiro‐Vieira, Vera Marisa Costa, José Alberto Duarte et al. (8 authors)
Biomedicine & Pharmacotherapy
Published: Feb 2018
11 citations
1083 days before retraction
Comprehensive review of cardiovascular toxicity of drugs and related agents
Přemysl Mladěnka, Lenka Applová, Jiří Patočka et al. (12 authors)
Medicinal Research Reviews Open Access
Published: Jan 2018
241 citations
1132 days before retraction
Central Nervous System Stimulants and Drugs That Suppress Appetite
Nicholas T. Bello, Matthew R. Zahner
Side effects of drugs annual
Published: Jan 2017
1501 days before retraction
Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes
José Martínez‐Raga, Amparo Ferreros, Carlos Knecht et al. (5 authors)
Therapeutic Advances in Drug Safety Open Access
Published: Nov 2016
34 citations
1534 days before retraction
Classics in Chemical Neuroscience: Methylphenidate
Cody J. Wenthur
ACS Chemical Neuroscience
Published: Jul 2016
55 citations
1672 days before retraction
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
Ju‐Young Shin, Elizabeth E. Roughead, Byung‐Joo Park et al. (4 authors)
BMJ Open Access
Published: May 2016
110 citations
1716 days before retraction
The cardiovascular safety of methylphenidate
John W. Jackson
BMJ Open Access
Published: May 2016
15 citations
1716 days before retraction
Rare Cardiac Effects of Methylphenidate: Mobitz Type 1 AV Block
Pınar Dervişoğlu, Mustafa Kösecik
Sakarya Medical Journal Open Access
Published: Jan 2016
1867 days before retraction
Central Nervous System Stimulants and Drugs That Suppress Appetite
Matthew R. Zahner, Nicholas T. Bello
Side effects of drugs annual
Published: Jan 2016
1867 days before retraction
Quick Stats
Total Citations: 21
Years Since Retraction: 4.8 years
Open Access: Yes
Last Checked: Jul 24, 2025